Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...
A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical ...
In my medical training in the 1960s and 70s, surgeons, who were almost exclusively males, often did not tell their women ...
Roche's CEO said on Wednesday that the Swiss drugmaker's oral drug candidate for breast cancer giredestrant could enter a ...
WEDNESDAY, Oct. 9, 2024 (HealthDay News) -- Cancer in young adults is rare, but the insurance coverage given them by the ...
Patients using a cancer centre in Surrey have praised the positive effects a new £6.2m redevelopment has had. The former St ...
Swiss Alpine skier Niels Hintermann was diagnosed with lymph node cancer and will miss the upcoming season to undergo ...
New data shows the breast cancer rate is growing each year in women under 50, with the highest increase in Asian American and ...